Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$59.06 - $75.72 $100,402 - $128,724
-1,700 Reduced 34.0%
3,300 $244,000
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $164,850 - $247,600
-2,500 Reduced 33.33%
5,000 $341,000
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $31,340 - $47,525
500 Added 7.14%
7,500 $704,000
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $23,595 - $35,385
500 Added 7.69%
7,000 $474,000
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $197,275 - $345,475
6,500 New
6,500 $321,000
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $106,830 - $228,690
-3,000 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $349,710 - $465,030
3,000 New
3,000 $395,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wellington Shields Capital Management, LLC Portfolio

Follow Wellington Shields Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.